Medetomidine

Medetomidine

SCHEMBL29945090

Cc1cccc(C(C)c2cnc[nH]2)c1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2C

The experimentally established mechanism targets of Medetomidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRA2A known ✓ P08913 11/20 1.00
ADRA2B known ✓ P18089 11/20 1.00
ADRA2C known ✓ P18825 11/20 1.00
ADRA1D P25100 8/20 1.00
ADRA1A P35348 7/20 1.00
ADRA1B P35368 6/20 1.00
KCNH2 Q12809 1/20 1.00
TP53 P04637 1/20 1.00
CYP1A2 P05177 1/20 1.00
CYP3A4 P08684 1/20 1.00
CYP2D6 P10635 1/20 1.00
CYP2C9 P11712 1/20 1.00
TSHR P16473 1/20 1.00
CYP2C19 P33261 1/20 1.00
SLC6A2 P23975 1/20 0.97
HTR7 P34969 1/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dexmedetomidine SCHEMBL31048740 1.00 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
Medetomidine SCHEMBL28305816 1.00 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
Dexmedetomidine SCHEMBL29363193 1.00 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
Medetomidine SCHEMBL787407 1.00 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
Dexmedetomidine SCHEMBL29546835 1.00 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
Dexmedetomidine SCHEMBL26433 1.00 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
Dexmedetomidine SCHEMBL30282088 0.98 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
Medetomidine SCHEMBL2202289 0.98 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
Dexmedetomidine SCHEMBL29833189 0.98 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
Dexmedetomidine SCHEMBL23498050 0.97 ADRA2A (0.94) ADRA2AADRA2BADRA2CADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092103-A1 Peptides for the Treatment of Retinitis Pigmentosa CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2025-03-20 US disclosed
CN-119654383-A Antifouling coating composition 中国涂料株式会社 2025-03-18 CN disclosed
EP-4499123-A2 PEPTIDES FOR THE TREATMENT OF RETINITIS PIGMENTOSA Consejo Superior De Investigaciones Científicas - CSIC (ES) 2025-02-05 EP disclosed
US-20240238385-A1 ISOLATED OR ARTIFICIAL NUCLEOTIDE SEQUENCES FOR USE IN NEURODEGENERATIVE DISEASES UNIVERSIDADE DO ALGARVE (PT) 2024-07-18 US disclosed
WO-2024089663-A1 MODIFIED CELLULAR BY-PRODUCT, METHODS AND USES THEREOF UNIVERSIDADE DE COIMBRA (PT) 2024-05-02 WO disclosed
EP-4337245-A1 ISOLATED OR ARTIFICIAL NUCLEOTIDE SEQUENCES FOR USE IN NEURODEGENERATIVE DISEASES Universidade Do Algarve (PT) 2024-03-20 EP disclosed
WO-2023180454-A2 PEPTIDES FOR THE TREATMENT OF RETINITIS PIGMENTOSA CONSEJO SUPERIOR DE INVESTIGACIONES (ES) 2023-09-28 WO disclosed
EP-4248985-A1 PEPTIDES FOR THE TREATMENT OF RETINITIS PIGMENTOSA Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2023-09-27 EP disclosed
WO-2022238974-A1 ISOLATED OR ARTIFICIAL NUCLEOTIDE SEQUENCES FOR USE IN NEURODEGENERATIVE DISEASES UNIVERSIDADE DO ALGARVE (PT) 2022-11-17 WO disclosed
CN-113840885-B Antifouling coating composition 日东化成株式会社 2022-11-15 CN disclosed